Impact of Specific Antimicrobials and Minimal Inhibitory Concentration(MIC) Values on the Outcome of Bloodstream Infections Due to ESBL or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Aminoglycosides; Beta lactamase inhibitors; Beta-lactams; Carbapenems; Cephalosporins; Colistin; Fluoroquinolones; Fosfomycin; Imipenem; Meropenem; Tigecycline
- Indications Enterobacteriaceae infections
- Focus Therapeutic Use
- Acronyms INCREMENT
- 27 Jun 2014 Biomarkers information updated
- 25 Jan 2013 New trial record
- 01 Jan 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.